The Pennsylvania House just took a stand that should make patients and parents breathe a little easier — and make bureaucrats and tech lobbyists squirm. This week the House passed House Bill 1925, a measure that would force hospitals, insurers, and other health providers to tell patients when artificial intelligence helped make a clinical decision. The vote was 144–59. The bill now heads to the Senate, and a separate resolution urging the federal government not to bully states on AI rules also cleared the House.
What HB1925 would actually require
Put simply: disclosure, paperwork, and human backup. HB1925 would require a health-care facility to disclose to a patient when AI systems are used to influence or make clinical decisions. Facilities and insurers that use AI for utilization reviews would have to file compliance attestations with state agencies. Importantly, the bill bars benefit‑termination decisions from being made by AI alone — a real person must sign off. The law would also protect clinicians from punishment if they contradict an AI recommendation.
Why this got bipartisan support — and why that matters
Don’t let the chamber-party math fool you: 41 Republicans joined every Democrat to pass the bill. That tells you two things. First, voters care about knowing who — or what — is calling the medical shots. Second, state leaders still believe Pennsylvania should decide Pennsylvania rules. The House also adopted a resolution pushing back on pressure from the federal executive branch to stop states from making their own AI laws. If you believe in states’ rights and patient choice, that’s not some partisan stunt — it’s common sense.
Balancing transparency with innovation
No one sensible is asking Pennsylvania to ban medical AI. Doctors and hospitals use powerful tools that can save lives. The hard work comes down to balance: require transparency and human review without wrecking clinical workflows or giving away trade secrets that help innovators compete. Hospitals and insurers will complain about added compliance costs. Vendors will grumble about revealing algorithm details. Those are real points. The Senate should hold hearings, hear from clinicians and patients, and write rules that protect both safety and innovation.
This bill is a common‑sense first step: tell patients when AI played a role, keep a human in the loop, and let the state hold actors accountable. If the Senate and governor keep that spirit, Pennsylvania can be a model for patient-first AI rules — not a lab for unchecked tech experiments or federal micromanagement. And for anyone who worries a robot is already deciding their care — rest easy, or at least ask the question. If a machine made the call, this bill would make sure you know who to blame. Or thank.
